Publications en collaboration avec des chercheurs de Centro de Investigacion Biomedica en Red de Enfermedades Respiratorias (107)

2024

  1. Engineering Protein-Nanoparticle Hybrids as Targeted Contrast Agents

    ACS Applied Materials and Interfaces, Vol. 16, Núm. 44, pp. 59849-59861

  2. Periodic table screening for enhanced positive contrast in MRI and in vivo uptake in glioblastoma

    Chemical Science, Vol. 15, Núm. 22, pp. 8578-8590

  3. Printable Poly(3,4-ethylenedioxythiophene)-Based Conductive Patches for Cardiac Tissue Remodeling

    ACS Applied Materials and Interfaces , Vol. 16, Núm. 27, pp. 34467-34479

  4. Sphingomyelinase-responsive nanomicelles for targeting atherosclerosis

    Nanoscale, Vol. 16, Núm. 13, pp. 6477-6487

2023

  1. A Comparative Study of Ultrasmall Calcium Carbonate Nanoparticles for Targeting and Imaging Atherosclerotic Plaque

    ACS Nano, Vol. 17, Núm. 14, pp. 13811-13825

  2. Assessment of Regional Lung Ventilation with Positron Emission Tomography Using the Radiofluorinated Gas [18F]SF6: Application to an Animal Model of Impaired Ventilation

    Molecular Imaging and Biology, Vol. 25, Núm. 2, pp. 413-422

  3. Author Correction: γ-Linolenic acid in maternal milk drives cardiac metabolic maturation (Nature, (2023), 618, 7964, (365-373), 10.1038/s41586-023-06068-7)

    Nature

  4. Biomimetic and Functional Nanomaterials for Molecular Imaging

    Pharmaceutics

  5. Comparison of Algorithms to Compute Relaxation Time Maps in Magnetic Resonance Imaging

    Applied Sciences (Switzerland), Vol. 13, Núm. 7

  6. Corrigendum: Impact of a TAK-1 inhibitor as a single or as an add-on therapy to riociguat on the metabolic reprograming and pulmonary hypertension in the SUGEN5416/hypoxia rat model (Frontiers in Pharmacology, (2023), 14, (1021535), 10.3389/fphar.2023.1021535)

    Frontiers in Pharmacology

  7. Design and fabrication of a microfluidic system with embedded circular channels for rotary cell culture

    Biotechnology Journal, Vol. 18, Núm. 7

  8. Impact of a TAK-1 inhibitor as a single or as an add-on therapy to riociguat on the metabolic reprograming and pulmonary hypertension in the SUGEN5416/hypoxia rat model

    Frontiers in Pharmacology, Vol. 14

  9. Luminescent Carbon Nanodots Doped with Gadolinium (III): Purification Criteria, Chemical and Biological Characterization of a New Dual Fluorescence/MR Imaging Agent

    Small, Vol. 19, Núm. 31

  10. Machine Learning-Assisted High-Throughput SERS Classification of Cell Secretomes

    Small, Vol. 19, Núm. 51

  11. Radiolabeled Iron Oxide Nanomaterials for Multimodal Nuclear Imaging and Positive Contrast Magnetic Resonance Imaging (MRI): A Review

    ACS Applied Nano Materials, Vol. 6, Núm. 22, pp. 20523-20538

  12. γ-Linolenic acid in maternal milk drives cardiac metabolic maturation

    Nature, Vol. 618, Núm. 7964, pp. 365-373

2022

  1. 2 deoxy-D-glucose augments the mitochondrial respiratory chain in heart

    Scientific reports, Vol. 12, Núm. 1, pp. 6890

  2. A Comprehensive Introduction to Magnetic Resonance Imaging Relaxometry and Contrast Agents

    ACS Omega, Vol. 7, Núm. 42, pp. 36905-36917

  3. Benchtop nuclear magnetic resonance-based metabolomic approach for the diagnosis of bovine tuberculosis

    Transboundary and Emerging Diseases, Vol. 69, Núm. 4, pp. e859-e870

  4. Heteroplasmy of Wild-Type Mitochondrial DNA Variants in Mice Causes Metabolic Heart Disease with Pulmonary Hypertension and Frailty

    Circulation, Vol. 145, Núm. 14, pp. 1084-1101